330 filings
Page 8 of 17
S-8
l439 sxnw
13 Sep 19
Registration of securities for employees
5:15pm
SUPPL
8miwi5gjtz
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
84e8pnsewrjqjbd1371r
6 Aug 19
Current report (foreign)
4:06pm
6-K
hq8r54dnerixw4sho6o2
6 Aug 19
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
lrxn9l
18 Jul 19
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
ovhuzwihxw
27 Jun 19
Dissident Withdraws the Consents of its Nominees from Consideration Prior to the AGM
12:00am
6-K
j0wc5z2mto6gewnx1qr
21 Jun 19
Shareholders can vote the YELLOW proxy even if they previously voted on the green proxy
6:30am
6-K
tvggdad1b93ws kxx8
19 Jun 19
Leading Independent Proxy Advisors Recommend Aurinia Shareholders Vote the YELLOW Proxy Card FOR All of Aurinia’s Director Nominees
6:30am
6-K
sg0envs ktn6f0bgr4
7 Jun 19
Aurinia Issues Letter to Shareholders
8:00am
6-K
w2ziwk
31 May 19
Aurinia Pharmaceuticals Announces Upcoming Annual General Meeting of Shareholders
8:30am
6-K
x9iyw8w xp
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
ku9ftpvjoq9
14 May 19
Current report (foreign)
4:04pm
6-K
rru230vsp
14 May 19
Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
4:02pm
6-K
cq8vfg2 olvk
10 May 19
Aurinia Pharmaceuticals Inc. 6-K
7:00am
6-K
topcp
30 Apr 19
Aurinia Further Strengthens Its Board of Directors with the Appointment of Dr. Daniel Billen
6:05am
6-K
kbuzbk37lnt4
11 Apr 19
Aurinia Pharmaceuticals Inc. 6-K
4:39pm
40-F
3eeqxaj y344bxyyf
19 Mar 19
Annual report (Canada)
4:16pm
6-K
bwityvtne
19 Mar 19
Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights
4:02pm
6-K
cf1hpjrp7
14 Mar 19
Aurinia Recognizes World Kidney Day and National Kidney Month with New Activities Focused on Raising Awareness for Kidney Disease
7:00am
6-K
dke6b 2zex
27 Feb 19
Aurinia Closes At-The-Market Facility
6:30am